Clinical Trial Update: A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, and pharmacokinetics of multiple oral doses of RO7795081 in otherwise healthy Chinese adults who are overweight …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• RO7795081

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Healthy Volunteers, Overweight or Obesity | Phase 1 | Status: RECRUITING